These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 32387166)

  • 1. Development of the Asthma Impairment and Risk Questionnaire (AIRQ): A Composite Control Measure.
    Murphy KR; Chipps B; Beuther DA; Wise RA; McCann W; Gilbert I; Eudicone JM; Gandhi HN; Harding G; Coyne KS; Zeiger RS;
    J Allergy Clin Immunol Pract; 2020; 8(7):2263-2274.e5. PubMed ID: 32387166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advancing assessment of asthma control with a composite tool: The Asthma Impairment and Risk Questionnaire.
    Chipps BE; Zeiger RS; Beuther DA; Wise RA; McCann W; Reibman J; George M; Gilbert I; Eudicone JM; Coyne KS; Harding G; Murphy KR
    Ann Allergy Asthma Immunol; 2024 Jul; 133(1):49-56. PubMed ID: 38494113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the German version of the Asthma Impairment and Risk Questionnaire (AIRQ).
    Kanniess F; Defosse K; Lommatzsch M; Schultz T; Timmermann H; Schmidt O; Heindl S; Baumann HJ; Buhl R; Taube C; Höing F; Korn S
    Pneumologie; 2024 Nov; 78(11):912-921. PubMed ID: 38991526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating construct validity of the Asthma Impairment and Risk Questionnaire using a 3-month exacerbation recall.
    Chipps BE; Murphy KR; Wise RA; McCann WA; Beuther DA; Reibman J; George M; Gilbert I; Eudicone JM; Gandhi HN; Harding G; Ross M; Zeiger RS
    Ann Allergy Asthma Immunol; 2022 May; 128(5):544-552.e3. PubMed ID: 35123077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Asthma Impairment and Risk Questionnaire (AIRQ) Control Level Predicts Future Risk of Asthma Exacerbations.
    Beuther DA; Murphy KR; Zeiger RS; Wise RA; McCann W; Reibman J; George M; Gilbert I; Eudicone JM; Gandhi HN; Ross M; Coyne KS; Chipps B
    J Allergy Clin Immunol Pract; 2022 Dec; 10(12):3204-3212.e2. PubMed ID: 35998877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Clinical Characteristics and Biomarkers on Asthma Impairment and Risk Questionnaire Exacerbation Prediction Ability.
    Murphy KR; Beuther DA; Chipps BE; Wise RA; McCann WA; Reibman J; George M; Gilbert I; Eudicone JM; Gandhi HN; Ross M; Coyne KS; Zeiger RS
    J Allergy Clin Immunol Pract; 2024 Aug; 12(8):2092-2101.e4. PubMed ID: 38705273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing meaningful change in the Asthma Impairment and Risk Questionnaire.
    McCann W; Murphy KR; Zeiger RS; Beuther DA; Wise RA; Reibman J; George M; Gilbert I; Eudicone JM; Gandhi HN; Cutts K; Coyne KS; Chipps B
    Ann Allergy Asthma Immunol; 2024 Aug; 133(2):152-158. PubMed ID: 38369256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Asthma Impairment and Risk Questionnaire enhances the assessment of asthma control.
    Chipps B; Zeiger RS; Beuther DA; Reibman J; Wise RA; McCann W; Gilbert I; Eudicone JM; Gandhi HN; Harding G; Cutts K; George M; Murphy KR
    Ann Allergy Asthma Immunol; 2023 Oct; 131(4):436-443.e1. PubMed ID: 37105501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship Between Asthma Control as Measured by the Asthma Impairment and Risk Questionnaire (AIRQ) and Patient Perception of Disease Status, Health-Related Quality of Life, and Treatment Adherence.
    Reibman J; Chipps BE; Zeiger RS; Beuther DA; Wise RA; McCann W; Gilbert I; Eudicone JM; Gandhi HN; Harding G; Cutts K; Coyne KS; Murphy KR; George M
    J Asthma Allergy; 2023; 16():59-72. PubMed ID: 36636702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive Properties of the Asthma Control Test and Its Component Questions for Severe Asthma Exacerbations.
    Cajigal S; Wells KE; Peterson EL; Ahmedani BK; Yang JJ; Kumar R; Burchard EG; Williams LK
    J Allergy Clin Immunol Pract; 2017; 5(1):121-127.e2. PubMed ID: 27544712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Validation of Personalized Prediction to Estimate Future Risk of Severe Exacerbations and Uncontrolled Asthma in Patients with Asthma, Using Clinical Parameters and Early Treatment Response.
    Boer S; Sont JK; Loijmans RJB; Snoeck-Stroband JB; Ter Riet G; Schermer TRJ; Assendelft WJJ; Honkoop PJ
    J Allergy Clin Immunol Pract; 2019 Jan; 7(1):175-182.e5. PubMed ID: 29936188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of asthma control according to Global Initiative for Asthma guidelines: a comparison with the Asthma Control Questionnaire.
    Olaguibel JM; Quirce S; Juliá B; Fernández C; Fortuna AM; Molina J; Plaza V;
    Respir Res; 2012 Jun; 13(1):50. PubMed ID: 22726416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validity of the Asthma Control Test Questionnaire Among Smoking Asthmatics.
    Soler X; Holbrook JT; Gerald LB; Berry CE; Saams J; Henderson RJ; Sugar E; Wise RA; Ramsdell JW
    J Allergy Clin Immunol Pract; 2018; 6(1):151-158. PubMed ID: 28669892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the asthma control test: a reliable determinant of disease stability and a predictor of future exacerbations.
    Ko FW; Hui DS; Leung TF; Chu HY; Wong GW; Tung AH; Ngai JC; Ng SS; Lai CK
    Respirology; 2012 Feb; 17(2):370-8. PubMed ID: 22107482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship of asthma impairment determined by psychometric tools to future asthma exacerbations.
    Schatz M; Zeiger RS; Yang SJ; Chen W; Crawford W; Sajjan S; Allen-Ramey F
    Chest; 2012 Jan; 141(1):66-72. PubMed ID: 21868465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a novel risk score for asthma exacerbations: The risk score for exacerbations.
    Bateman ED; Buhl R; O'Byrne PM; Humbert M; Reddel HK; Sears MR; Jenkins C; Harrison TW; Quirce S; Peterson S; Eriksson G
    J Allergy Clin Immunol; 2015 Jun; 135(6):1457-64.e4. PubMed ID: 25258144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the National Heart, Lung, and Blood Institute guidelines impairment domain for classifying asthma control and predicting asthma exacerbations.
    Zeiger RS; Yegin A; Simons FE; Haselkorn T; Rasouliyan L; Szefler SJ; Chipps BE;
    Ann Allergy Asthma Immunol; 2012 Feb; 108(2):81-7. PubMed ID: 22289725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The strategy for predicting future exacerbation of asthma using a combination of the Asthma Control Test and lung function test.
    Sato R; Tomita K; Sano H; Ichihashi H; Yamagata S; Sano A; Yamagata T; Miyara T; Iwanaga T; Muraki M; Tohda Y
    J Asthma; 2009 Sep; 46(7):677-82. PubMed ID: 19728204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can the Asthma Control Questionnaire be used to differentiate between patients with controlled and uncontrolled asthma symptoms? A pilot study.
    van den Nieuwenhof L; Schermer T; Eysink P; Halet E; van Weel C; Bindels P; Bottema B
    Fam Pract; 2006 Dec; 23(6):674-81. PubMed ID: 16880177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy of childhood asthma control test among Thai childhood asthma patients.
    Sommanus S; Direkwattanachai C; Lawpoolsri S; Sitcharungsi R
    Asian Pac J Allergy Immunol; 2018 Sep; 36(3):152-158. PubMed ID: 29223149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.